Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000817933 | SCV000958520 | pathogenic | Granulomatous disease, chronic, X-linked | 2021-07-14 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 1-3 of the CYBB gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 3 of the CYBB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYBB are known to be pathogenic (PMID: 9585602, 20729109). A deletion of exons 1-3 has been observed in an individual affected with X-linked chronic granulomatous disease (PMID: 9454688). For these reasons, this variant has been classified as Pathogenic. |